Scipher Medicine® to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

WALTHAM, Mass.–(BUSINESS WIRE)–Scipher Medicine, a precision immunology company matching patients with their most effective therapies, today announced that Alif Saleh, Chief Executive Officer, and John Strumbos, Chief Financial Officer will present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 18, 2021, at 9:00 a.m. ET, and will participate in one-on-one investor meetings.

About Scipher Medicine®

Scipher Medicine, a precision immunology company matching patients with their most effective therapies, believes that patients deserve simple answers to treatment options based on scientifically backed data. Using spectra™, our proprietary network medicine platform, and artificial intelligence, we commercialize blood tests revealing a person’s unique molecular disease signature and match it to the most effective therapy, ensuring optimal treatment from day one. The patient molecular data generated from our tests further supports the discovery and development of novel and more effective therapeutics. We partner with leading payers, providers, and pharmaceutical companies to bring precision medicine to autoimmune diseases. Visit http://www.sciphermedicine.com and follow Scipher Medicine on Twitter, Facebook, and LinkedIn.

Contacts

Scipher Medicine:
Media Relations

Matt Burns

VP, Head of Communications

PR@scipher.com
518-423-5907

Investor Relations

John Strumbos, Ph.D., MBA

Chief Financial Officer

IR@scipher.com